Volition is a global healthcare organization dedicated to transforming early disease detection for both humans and animals. The company is focused on creating uncomplicated, cost-efficient examinations that assess nucleosomes present in the bloodstream to detect cancer and other illnesses at an early stage, even prior to the onset of symptoms. The primary goal is to save lives, with the aim of integrating disease screening into everyday practices, similar to routine cholesterol or pregnancy testing, in order to facilitate early disease detection. The company has recently introduced its inaugural product through its veterinary division, Volition Veterinary.